3D Medicines, Inc.(HK:1244)
HK$2.60+0.02 (+0.78%)
HK:1244
3D Medicines, Inc. financials statements
HK$2.60
At close:+0.02 (+0.78%)
Want to see HK:1244 full AI Analyst Report?
3D Medicines, Inc. (1244) Financial Statements
3 Followers
3D Medicines, Inc. Financial Overview
3D Medicines, Inc.'s market cap is currently ¥666.10M. The company's EPS TTM is ¥-0.71; its P/E ratio is -3.12; 3D Medicines, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 356.09M | ¥ 445.65M | ¥ 634.95M | ¥ 567.39M | ¥ 60.26M |
| Gross Profit | ¥ 298.97M | ¥ 371.74M | ¥ 524.01M | ¥ 525.18M | ¥ 55.98M |
| Operating Income | ¥ -112.65M | ¥ -123.43M | ¥ -497.25M | ¥ -386.17M | ¥ -516.25M |
| EBITDA | ¥ -191.18M | ¥ -209.56M | ¥ -529.23M | ¥ -1.03B | ¥ -1.45B |
| Net Income | ¥ -177.53M | ¥ -182.66M | ¥ -524.70M | ¥ -1.02B | ¥ -1.43B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 438.10M | ¥ 840.98M | ¥ 996.58M | ¥ 942.03M | ¥ 824.48M |
| Total Assets | ¥ 936.64M | ¥ 1.22B | ¥ 1.43B | ¥ 1.33B | ¥ 1.06B |
| Total Debt | ¥ 152.85M | ¥ 237.62M | ¥ 282.43M | ¥ 175.70M | ¥ 3.15B |
| Net Debt | ¥ -17.46M | ¥ -206.70M | ¥ -384.05M | ¥ -521.04M | ¥ 2.38B |
| Total Liabilities | ¥ 391.54M | ¥ 512.54M | ¥ 558.20M | ¥ 436.65M | ¥ 3.33B |
| Stockholders' Equity | ¥ 596.98M | ¥ 785.06M | ¥ 936.74M | ¥ 943.00M | ¥ -2.24B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -149.87M | ¥ -249.60M | ¥ -150.74M | ¥ -332.76M | ¥ -433.46M |
| Operating Cash Flow | ¥ -149.85M | ¥ -210.58M | ¥ -144.41M | ¥ -278.78M | ¥ -377.08M |
| Investing Cash Flow | ¥ -26.20M | ¥ 17.95M | ¥ -187.58M | ¥ -242.11M | ¥ -98.87M |
| Financing Cash Flow | ¥ -89.56M | ¥ -33.92M | ¥ 304.51M | ¥ 408.41M | ¥ 840.08M |
Currency in CNY
